Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.86 USD | -1.62% | +12.76% | -46.00% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 31/12/13 |
Peter Wolfe
DFI | Director of Finance/CFO | 56 | 11/12/22 |
Pablo Guzman
CTO | Chief Tech/Sci/R&D Officer | 74 | 31/12/22 |
Karen Cashmere
PRN | Corporate Officer/Principal | 71 | 11/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 31/12/13 |
Robert Finizio
BRD | Director/Board Member | 53 | 30/11/22 |
James Sapirstein
BRD | Director/Board Member | 63 | 04/01/23 |
Gregory Freitag
BRD | Director/Board Member | 62 | 04/01/23 |
Min-Chul Park
BRD | Director/Board Member | 42 | 30/11/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,062 | 0 | 0 | 99.24 % |
Stock B | 1 | 834,902 | 828,597 ( 99.24 %) | 6 ( 0.000743 %) | |
Stock C | 0 | 50 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.00% | 3.69M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.14% | 22.48B | |
-9.35% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ZVSA Stock
- Company ZyVersa Therapeutics, Inc.